Advertisement

Topics

Adcetris gets Japanese approval for Hodgkin lymphoma

06:17 EDT 24 Sep 2018 | SmartBrief

Seattle Genetics' Adcetris, or brentuximab vedotin, in combination with dacarbazine, doxorubicin and vinblastine, has receive -More

Original Article: Adcetris gets Japanese approval for Hodgkin lymphoma

NEXT ARTICLE

More From BioPortfolio on "Adcetris gets Japanese approval for Hodgkin lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement